
|Articles|August 1, 2004
FDA approves Botox for hyperhidrosis tx
Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Journal Digest: September 2, 2026
3
Dermatology Times Launches Derm Nexus Congress for NPs and PAs
4
Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis
5







